You are using IE 8 or below so some features may not work. Please upgrade to a modern browser
Ihr Webbrowser ist veraltet und wird leider nicht in vollem Umfang unterstützt.

PATENTS & PUBLICATIONS

PATENTS

Method and device for producing lipid vesicles
granted by: AU 2002215987; CA 2,427,640; EP 1337322; US 6,843,942

Application of superoxide dismutase in liposomes
granted by: AU 690377; CA 2,204,493; EP 0789584; MX 206295; NZ 296098; US 5,942,245; US 6,312,720

Superloaded liposomes for drug delivery
granted by: AU 2005247091; CA 2,567,961; CN 1960706A; EA 200602172; EP 1748760; IN 244478; KR 1212377

Liposomal composition comprising an active ingredient for relaxing smooth muscle production and therapeutically use of said composition
granted by: AU 04024753.8; CA 2,583,332; EA 011391; EP 1802277; JP 5688199; KR 1289917; NZ 554183; US 8,524,274

SELECTED PUBLICATIONS

Storka A, Vcelar B, Klickovic U, Gouya G, Weisshaar S, Aschauer S, Bolger G, Helson L, Wolzt M (2015) Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans. Int J Clin Pharmacol Ther 53(1):54-65

Koutsoulas C, Suleiman E, Wagner A, Žabka M (2014) Comparative study between synthetic and phospholipids of natural origin: effect of phospholipid selection on the behaviour of a topical liposomal dosage form incorporating terbinafie. J Liposome Res 24(4):336-43

Rodrigueza WV, Woolliscroft MJ, Ebrahim AS, Forgey R, McGovren PJ, Endert G, Wagner A, Holewa D, Aboukameel A, Gill RD, Bisgaier CL, Messmann RA, Whitehead CE, Izbicka E, Streeper R, Wick MC, Stiegler G, Stein CA, Monsma D, Webb C, Sooch MP, Panzner S, Mohammad R, Goodwin NC, Al-Katib A (2014) Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide. Cancer Chemother Pharmacol 74(1):151-66

Katinger D, Wagner A, Luque I, Crespillo S, Conejero-Lara F, Roger M, Martin C, Mouz N, Mourao S, Farsang A, Notka F, Malcolm K, Bosquet N, Le Grand R, Moog C, Cope A, Shattock R, Lewis DJ, El Habib R (2012) Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans. Retrovirology 9 (Suppl 2):354

Birnbaumer G, Küpcü S, Jungreuthmayer C, Richter L, Vorauer-Uhl K, Wagner A, Valenta C, Sleytr U, Ertl P (2011) Rapid liposome quality assessment using a lab-on-a-chip. Lab Chip. 11(16):2753-62

Wagner A, Vorauer-Uhl K (2011) Liposome Technology for Industrial Purposes. Journal of Drug Delivery 2011, 9 pages

Wagner A, Stiegler G, Vorauer-Uhl K, Katinger H, Quendler H, Hinz A, Weissenhorn W (2007) One Step Membrane Incorporation of Viral Antigens as a Vaccine Candidate Against HIV. J Liposome Res 17(3):139-54

Wagner A, Platzgummer M, Kreismayr G, Quendler H, Stiegler G, Ferko B, Vecera G, Vorauer-Uhl K, Katinger H (2006) GMP Production of Liposomes-A New Industrial Approach. J Liposome Res 16(3):311-9

Vorauer-Uhl K, Wagner A, Borth N, Katinger H (2002) Long term stability of rh-Cu/Zn-SOD-liposomes prepared by the crossflow injection technique following ICH-guidelines. European Journal of Pharmaceutics and Biopharmaceutics 54:77-81

Wagner A, Vorauer-Uhl K, Kreismayr G, Katinger H (2002) Enhanced protein loading into liposomes by the multiple injection technique. Journal of Liposome Research 12(3):271-83

Wagner A, Vorauer-Uhl K, Kreismayr G, Katinger H (2002) The crossflow injection technique - an improvement of the ethanol injection method. Journal of Liposome Research 12(3):259-70

Wagner A, Vorauer-Uhl K, Katinger H (2002) Liposome produced in a pilot scale: production, purification and efficiency aspects. European Journal of Pharmaceutics and Biopharmaceutics 54:213-9

MEET US AT

Controlled Release Society Annul Meeting
July 16-19, 2017

Boston, USA

Dr. Andreas Wagner
 

ILS Liposome Advances and Liposome Research Days
September 16-18

Athens, Greece

Dr. Andreas Wagner
Dr. Charalampos Koutsoulas

DOWNLOAD LIPOSOMAL BROCHURE

Polymun Liposome Technology 
Broschure (pdf, 1MB)